These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11228143)

  • 1. Immunology. Giving inhibitory receptors a boost.
    Lin SY; Kinet JP
    Science; 2001 Jan; 291(5503):445-6. PubMed ID: 11228143
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.
    Samuelsson A; Towers TL; Ravetch JV
    Science; 2001 Jan; 291(5503):484-6. PubMed ID: 11161202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiinflammatory IgG.
    Kaveri SV; Lacroix-Desmazes S; Bayry J
    N Engl J Med; 2008 Jul; 359(3):307-9. PubMed ID: 18635437
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of action of intravenous immunoglobulins.
    Baerenwaldt A; Biburger M; Nimmerjahn F
    Expert Rev Clin Immunol; 2010 May; 6(3):425-34. PubMed ID: 20441428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity.
    Crow AR; Song S; Freedman J; Helgason CD; Humphries RK; Siminovitch KA; Lazarus AH
    Blood; 2003 Jul; 102(2):558-60. PubMed ID: 12649142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective mechanisms of IVIG.
    Clynes R
    Curr Opin Immunol; 2007 Dec; 19(6):646-51. PubMed ID: 18032008
    [No Abstract]   [Full Text] [Related]  

  • 7. Phosphoinositides in FCgamma receptor signaling.
    Booth JW
    Front Biosci; 2006 May; 11():1264-74. PubMed ID: 16368512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.
    Anthony RM; Nimmerjahn F; Ashline DJ; Reinhold VN; Paulson JC; Ravetch JV
    Science; 2008 Apr; 320(5874):373-6. PubMed ID: 18420934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The isotype of autoantibodies influences the phagocytosis of antibody-coated platelets in autoimmune thrombocytopenic purpura.
    Hoemberg M; Stahl D; Schlenke P; Sibrowski W; Pachmann U; Cassens U
    Scand J Immunol; 2011 Nov; 74(5):489-95. PubMed ID: 21790706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells.
    Bazin R; Lemieux R; Tremblay T; St-Amour I
    Br J Haematol; 2004 Oct; 127(1):90-6. PubMed ID: 15384982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of anti-inflammatory activity of intravenous immunoglobulin via inhibitory Fcgamma receptors.
    Maródi L
    Pediatr Res; 2001 Nov; 50(5):551. PubMed ID: 11641444
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.
    Song S; Crow AR; Freedman J; Lazarus AH
    Blood; 2003 May; 101(9):3708-13. PubMed ID: 12506021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
    Siragam V; Brinc D; Crow AR; Song S; Freedman J; Lazarus AH
    J Clin Invest; 2005 Jan; 115(1):155-60. PubMed ID: 15630455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fc gamma RIIB as a potential molecular target for intravenous gamma globulin therapy.
    Ott VL; Fong DC; Cambier JC
    J Allergy Clin Immunol; 2001 Oct; 108(4 Suppl):S95-8. PubMed ID: 11586273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IVIg-mediated amelioration of murine ITP via FcgammaRIIb is not necessarily independent of SHIP-1 and SHP-1 activity.
    van Mirre E; van Royen A; Hack CE
    Blood; 2004 Mar; 103(5):1973; author reply 1974. PubMed ID: 14976068
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.
    Crow AR; Song S; Siragam V; Lazarus AH
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):710-3. PubMed ID: 16933274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG Fc receptor polymorphisms in human disease: implications for intravenous immunoglobulin therapy.
    Binstadt BA; Geha RS; Bonilla FA
    J Allergy Clin Immunol; 2003 Apr; 111(4):697-703. PubMed ID: 12704346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The unexpected complexity of Fc gamma RIIB signal transduction.
    Cambier JC; Fong D; Tamir I
    Curr Top Microbiol Immunol; 1999; 244():43-55. PubMed ID: 10453648
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpura.
    Crow AR; Lazarus AH
    J Pediatr Hematol Oncol; 2003 Dec; 25 Suppl 1():S14-8. PubMed ID: 14668633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors.
    Ortiz DF; Lansing JC; Rutitzky L; Kurtagic E; Prod'homme T; Choudhury A; Washburn N; Bhatnagar N; Beneduce C; Holte K; Prenovitz R; Child M; Killough J; Tyler S; Brown J; Nguyen S; Schwab I; Hains M; Meccariello R; Markowitz L; Wang J; Zouaoui R; Simpson A; Schultes B; Capila I; Ling L; Nimmerjahn F; Manning AM; Bosques CJ
    Sci Transl Med; 2016 Nov; 8(365):365ra158. PubMed ID: 27856797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.